Hainan Shuangcheng Pharmaceuticals (SHE:002693) unit Ningbo Shuangcheng obtained an amended drug manufacturing license from the Zhejiang regulator.
The amendment added Guangzhou Jiurui Pharmaceutical as an entrusted manufacturer for memantine hydrochloride tablets, according to a Tuesday filing with the Shenzhen bourse.
The license remains valid until Nov. 13, 2027, with no other changes.
Shares of the pharmaceutical company closed 5% lower Tuesday.
KT (KRX:030200) posted first-quarter net income attributable to shareholders of 352.2 billion won, down 35% from 539.8 billion won a year earlier, according to a Tuesday filing with the Korea Exchange.The South Korean telecommunications giant's sales fell 1% year over year to 6.778 trillion won from 6.845 trillion won.Shares of KT rose nearly 2% at market close.
Hanwha Life Insurance (KRX:088350) posted first-quarter net income attributable to shareholders of 324.4 billion won, up 44% from 226.06 billion won a year earlier, according to a Tuesday filing with the Korea Exchange.The South Korean insurance firm's sales jumped 55% year over year to 9.985 trillion won from 6.455 trillion won.Shares of Hanwha Life Insurance rose more than 3% at market close.
LG CNS (KRX:064400) secured an information strategic planning consulting project for Korea Electric Power Corp's (KRX:015760) next-generation sales and distribution system.The South Korean artificial intelligence and cloud computing company said Tuesday it will overhaul the operational framework of the electric utility's sales and distribution system to support and boost its public services.Shares of LG CNS added nearly 4% while those of Korea Electric Power fell about 5% at market close.